|9 Months Ended|
Sep. 30, 2021
|Stockholders' Equity Note [Abstract]|
|Schedule of common stock outstanding||
The following table summarizes the common stock activity for the three and nine months ended September 30, 2021 and 2020:
|Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]||
The following instruments were excluded from the calculation of diluted shares outstanding because the effect of including them would have been anti-dilutive.
Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef